scispace - formally typeset
Search or ask a question
Institution

University of Milan

EducationMilan, Italy
About: University of Milan is a education organization based out in Milan, Italy. It is known for research contribution in the topics: Population & Medicine. The organization has 58413 authors who have published 139784 publications receiving 4636354 citations. The organization is also known as: Università degli Studi di Milano & Statale.


Papers
More filters
Journal ArticleDOI
TL;DR: The role of the Tear Film and Ocular Surface Society (TFOS) Dry Eye Workshop (DEWS) II Diagnostic Methodology Subcommittee was to identify tests used to diagnose and monitor dry eye disease (DED) to identify those most appropriate to fulfil the definition of DED and its sub-classifications.
Abstract: The role of the Tear Film and Ocular Surface Society (TFOS) Dry Eye Workshop (DEWS) II Diagnostic Methodology Subcommittee was 1) to identify tests used to diagnose and monitor dry eye disease (DED), 2) to identify those most appropriate to fulfil the definition of DED and its sub-classifications, 3) to propose the most appropriate order and technique to conduct these tests in a clinical setting, and 4) to provide a differential diagnosis for DED and distinguish conditions where DED is a comorbidity. Prior to diagnosis, it is important to exclude conditions that can mimic DED with the aid of triaging questions. Symptom screening with the DEQ-5 or OSDI confirms that a patient might have DED and triggers the conduct of diagnostic tests of (ideally non-invasive) breakup time, osmolarity and ocular surface staining with fluorescein and lissamine green (observing the cornea, conjunctiva and eyelid margin). Meibomian gland dysfunction, lipid thickness/dynamics and tear volume assessment and their severity allow sub-classification of DED (as predominantly evaporative or aqueous deficient) which informs the management of DED. Videos of these diagnostic and sub-classification techniques are available on the TFOS website. It is envisaged that the identification of the key tests to diagnose and monitor DED and its sub-classifications will inform future epidemiological studies and management clinical trials, improving comparability, and enabling identification of the sub-classification of DED in which different management strategies are most efficacious.

1,152 citations

Journal ArticleDOI

1,150 citations

Journal ArticleDOI
07 Dec 2006-Nature
TL;DR: Findings show that the BMP–BMPR signalling system—which controls the activity of normal brain stem cells—may also act as a key inhibitory regulator of tumour-initiating, stem-like cells from GBMs and identify BMP4 as a novel, non-cytotoxic therapeutic effector, which may be used to prevent growth and recurrence of GBMs in humans.
Abstract: Transformed, oncogenic precursors, possessing both defining neural-stem-cell properties and the ability to initiate intracerebral tumours, have been identified in human brain cancers. Here we report that bone morphogenetic proteins (BMPs), amongst which BMP4 elicits the strongest effect, trigger a significant reduction in the stem-like, tumour-initiating precursors of human glioblastomas (GBMs). Transient in vitro exposure to BMP4 abolishes the capacity of transplanted GBM cells to establish intracerebral GBMs. Most importantly, in vivo delivery of BMP4 effectively blocks the tumour growth and associated mortality that occur in 100% of mice after intracerebral grafting of human GBM cells. We demonstrate that BMPs activate their cognate receptors (BMPRs) and trigger the Smad signalling cascade in cells isolated from human glioblastomas (GBMs). This is followed by a reduction in proliferation, and increased expression of markers of neural differentiation, with no effect on cell viability. The concomitant reduction in clonogenic ability, in the size of the CD133+ population and in the growth kinetics of GBM cells indicates that BMP4 reduces the tumour-initiating cell pool of GBMs. These findings show that the BMP-BMPR signalling system--which controls the activity of normal brain stem cells--may also act as a key inhibitory regulator of tumour-initiating, stem-like cells from GBMs and the results also identify BMP4 as a novel, non-cytotoxic therapeutic effector, which may be used to prevent growth and recurrence of GBMs in humans.

1,138 citations

Book ChapterDOI
Wil M. P. van der Aalst1, Wil M. P. van der Aalst2, A Arya Adriansyah2, Ana Karla Alves de Medeiros3, Franco Arcieri4, Thomas Baier5, Tobias Blickle6, Jagadeesh Chandra Bose2, Peter van den Brand, Ronald Brandtjen, Joos C. A. M. Buijs2, Andrea Burattin7, Josep Carmona8, Malu Castellanos9, Jan Claes10, Jonathan Cook11, Nicola Costantini, Francisco Curbera12, Ernesto Damiani13, Massimiliano de Leoni2, Pavlos Delias, Boudewijn F. van Dongen2, Marlon Dumas14, Schahram Dustdar15, Dirk Fahland2, Diogo R. Ferreira16, Walid Gaaloul17, Frank van Geffen18, Sukriti Goel19, CW Christian Günther, Antonella Guzzo20, Paul Harmon, Arthur H. M. ter Hofstede1, Arthur H. M. ter Hofstede2, John Hoogland, Jon Espen Ingvaldsen, Koki Kato21, Rudolf Kuhn, Akhil Kumar22, Marcello La Rosa1, Fabrizio Maria Maggi2, Donato Malerba23, RS Ronny Mans2, Alberto Manuel, Martin McCreesh, Paola Mello24, Jan Mendling25, Marco Montali26, Hamid Reza Motahari-Nezhad9, Michael zur Muehlen27, Jorge Munoz-Gama8, Luigi Pontieri28, Joel Ribeiro2, A Anne Rozinat, Hugo Seguel Pérez, Ricardo Seguel Pérez, Marcos Sepúlveda29, Jim Sinur, Pnina Soffer30, Minseok Song31, Alessandro Sperduti7, Giovanni Stilo4, Casper Stoel, Keith D. Swenson21, Maurizio Talamo4, Wei Tan12, Christopher Turner32, Jan Vanthienen33, George Varvaressos, Eric Verbeek2, Marc Verdonk34, Roberto Vigo, Jianmin Wang35, Barbara Weber36, Matthias Weidlich37, Ton Weijters2, Lijie Wen35, Michael Westergaard2, Moe Thandar Wynn1 
01 Jan 2012
TL;DR: This manifesto hopes to serve as a guide for software developers, scientists, consultants, business managers, and end-users to increase the maturity of process mining as a new tool to improve the design, control, and support of operational business processes.
Abstract: Process mining techniques are able to extract knowledge from event logs commonly available in today’s information systems. These techniques provide new means to discover, monitor, and improve processes in a variety of application domains. There are two main drivers for the growing interest in process mining. On the one hand, more and more events are being recorded, thus, providing detailed information about the history of processes. On the other hand, there is a need to improve and support business processes in competitive and rapidly changing environments. This manifesto is created by the IEEE Task Force on Process Mining and aims to promote the topic of process mining. Moreover, by defining a set of guiding principles and listing important challenges, this manifesto hopes to serve as a guide for software developers, scientists, consultants, business managers, and end-users. The goal is to increase the maturity of process mining as a new tool to improve the (re)design, control, and support of operational business processes.

1,135 citations

Journal ArticleDOI
15 Jan 1998-Nature
TL;DR: It is shown that coactivation of the AMPA/kainate and metabotropic glutamate receptors (mGluRs) on astrocytes stimulates these cells to release glutamate through a Ca2+-dependent process mediated by prostaglandins, revealing a new pathway of regulated transmitter release from astroCytes and outlining the existence of an integrated glutamatergic cross-talk between neurons and astroicytes in situ.
Abstract: Astrocytes in the brain form an intimately associated network with neurons. They respond to neuronal activity and synaptically released glutamate by raising intracellular calcium concentration ([Ca2+]i)1,2 which could represent the start of back-signalling to neurons3,4,5. Here we show that coactivation of the AMPA/kainate and metabotropic glutamate receptors (mGluRs) on astrocytes stimulates these cells to release glutamate through a Ca2+-dependent process mediated by prostaglandins. Pharmacological inhibition of prostaglandin synthesis prevents glutamate release, whereas application of prostaglandins (in particular PGE2) mimics and occludes the releasing action of GluR agonists. PGE2 promotes Ca2+-dependent glutamate release from cultured astrocytes and also from acute brain slices under conditions that suppress neuronal exocytotic release. When applied to the CA1 hippocampal region, PGE2 induces increases in [Ca2+]i both in astrocytes and in neurons. The [Ca2+]i increase in neurons is mediated by glutamate released from astrocytes, because it is abolished by GluR antagonists. Our results reveal a new pathway of regulated transmitter release from astrocytes and outline the existence of an integrated glutamatergic cross-talk between neurons and astrocytes in situ that may play critical roles in synaptic plasticity and in neurotoxicity.

1,134 citations


Authors

Showing all 58902 results

NameH-indexPapersCitations
Yi Cui2201015199725
Peter J. Barnes1941530166618
Thomas C. Südhof191653118007
Charles A. Dinarello1901058139668
Alberto Mantovani1831397163826
John J.V. McMurray1781389184502
Giuseppe Remuzzi1721226160440
Russel J. Reiter1691646121010
Jean Louis Vincent1611667163721
Tobin J. Marks1591621111604
Tomas Hökfelt158103395979
José Baselga156707122498
Naveed Sattar1551326116368
Silvia Franceschi1551340112504
Frederik Barkhof1541449104982
Network Information
Related Institutions (5)
Sapienza University of Rome
155.4K papers, 4.3M citations

97% related

University of Padua
114.8K papers, 3.6M citations

97% related

University of Bologna
115.1K papers, 3.4M citations

97% related

Utrecht University
139.3K papers, 6.2M citations

94% related

Radboud University Nijmegen
83K papers, 3.2M citations

94% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
2023240
2022777
20219,390
20209,000
20197,475
20186,804